Jump to content

Search the hub

Showing results for tags 'Regulatory issue'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Categories

  • Files

Calendars

  • Community Calendar

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 473 results
  1. News Article
    Thousands of women are being missed off the breast implant registry, new figures suggest. Data from NHS Digital, which manages the register, implies that around 8500 women across England and Scotland have not been added to the register after they were fitted with an implant last year. The register was recommended as a result of the breast implant scandal which saw some women fitted with faulty implants. It records the details of every person who has breast implant surgery in case of a product recall or another safety concern. But the latest figures suggest that many are being missed off the register and NHS Digital has asked women undergoing such treatment to ensure their surgeon has registered their details. The figures show that operations on 10,500 people were recorded in 2020. But officials have estimated this represents around 55% of the total number of cases. This means that approximately 8485 people were not added. Lee Martin, NHS breast surgeon and chairman of the Breast and Cosmetic Implant Registry steering group, said: "We want all patients, past and present, to be aware that the registry exists and ensure they are included by speaking to their surgeons." "As a surgeon, I know first-hand the importance of patient information being included on the registry, it's crucial in providing good patient care and provides patients with assurance that they will be followed up with if there are issues with their breast implants in the future." Read full story Source: Medscape, 10 November 2021
  2. News Article
    The High Court in Canberra, Australia, has ruled against big pharma giants Johnson and Johnson's application to appeal the Federal Court’s decision in favour of the survivors of their defective medical devices in November 2019. This means the decision of the Full Federal Court, in favour of the Lead Applicant and group members, will stand. Shine Lawyers', which has led the class action, has launched further actions against American Medical Systems (AMS), another manufacturer of mesh and tape implants supplied in Australia. The AMS implants, which are used to treat pelvic organ prolapse and stress urinary incontinence, have left many Australian women with severe complications. The legal group has also moved against Boston Scientific for defective vaginal mesh and sling implants received by women in Australia and opened a second Ethicon / Johnson & Johnson’s on behalf of women implanted with a defective mesh product on or after 4 July 2017. The class actions were filed in the Federal court and MIA believe other class actions, including hernia mesh, are underway. Kath Sansom, founder of the Sling the Mesh campaign, said "Brilliant news from Australia! Johnson & Johnson Loses High Court Appeal against the pelvic mesh verdict of 2019. This means J&J can no longer appeal the verdict! I realise compensation may still take time to be awarded to the 10,000+ mesh injured but at least the appeals are over! Congratulations to all the Australian mesh campaigners!" Read press release
  3. News Article
    A decade after scientists identified a link between certain implants and cancer, the US Food and Drug Administration has ordered “black box” warnings and a new checklist of risks for patients to review. Federal regulators have placed so-called black box warnings on breast implant packaging and told manufacturers to sell the devices only to health providers who review the potential risks with patients before surgery. Both the warnings and a new checklist that advises patients of the risks and side effects state that breast implants have been linked to a cancer of the immune system and to a host of other chronic medical conditions, including autoimmune diseases, joint pain, mental confusion, muscle aches and chronic fatigue. Startlingly, the checklist identifies particular types of patients who are at higher risk for illness after breast implant surgery. The group includes breast cancer patients who have had, or plan to have, chemotherapy or radiation treatments. That represents a large percentage of women who until now were encouraged to have breast reconstruction with implants following their treatment. Reactions to the new requirements were mixed. While some doctors welcomed the new warning system, others worried that the potential risks and side effects would not be conveyed adequately by plastic surgeons who were eager to reassure patients the procedure is safe and that the new checklist would be handled in a dismissive manner. But Dr. Mark Clemens, a professor at M.D. Anderson Cancer Center in Houston who serves a liaison to the F.D.A. for the American Society of Plastic Surgeons Society, said the black box warning and checklist represented “a huge step forward for patient safety and implants.” Read full story Source: The New York Times, 27 October 2021
  4. News Article
    The Care Quality Commission (CQC) has published State of Care. The report, which draws on the experiences of care people have shared with Healthwatch England, has found that health and social care services face some highly concerning challenges, including: A workforce drained in terms of resilience and capacity, especially in social care, where the staff vacancy rate has risen; A rising number of people seeking emergency care, leading to unacceptable waiting times; and Tackling the health inequalities that the COVID-19 pandemic has exacerbated. The report welcomes the additional funding that the Government has allocated to help the NHS and social care address their challenges. However, CQC has called for the extra investment to be used to: Develop new ways of working and don’t just prop up existing approaches and plug demand in acute care; and Improve the training, career development and terms and conditions of social care workers to help attract and retain more staff. CQC has also recommended that the short-term funding - currently in place to help discharge patients who are no longer in need of hospital care but may still require care services - be extended. The HealthWatch response Responding, Sir Robert Francis QC, Chair of Healthwatch England said: “During the pandemic, people have told us about the challenges they have faced. Whether this not being able to access dental care, problems using online GP services or being discharged from the hospital without the proper support. It’s great to see this report drawing so much on the experiences people have shared with us. “We urge Government to act on this report. The health and care system upon which we all depend is facing a hard winter, but, as this report makes clear, the longer-term picture is also challenging. “The steps the CQC are recommending, like extending the extra funding to help people leave hospital safely and ensuring there is enough dental capacity, will help give services the breathing space they need to get through this winter. “However, come spring we need to grasp the opportunity to build a better NHS and social care system. A system that tackles heath inequalities head-on, ensuring that no matter who you are or where you live, you can access high-quality care that meets your needs. A system that is sustainable, is designed round the needs of people and breaks perennial cycle of winter crises.” Original source: HealthWatch CQC report here
  5. News Article
    The care model run by independent sector mental health and learning disability hospitals is ‘inherently risky’, a Care Quality Commission (CQC) chief inspector has warned. Speaking at the NHS Providers conference, Ted Baker, chief inspector of hospitals for the Care Quality Commission, unveiled the regulator’s plans to change how it inspects health and care services. When asked by HSJ how its new “streamlined” approach would be applied to inpatient units run by the independent sector for people with mental health and learning disability, Professor Baker said: ”One of the things we’ve been doing during the pandemic, and will continue in our transitional approach, is target risk. And one of the risks we have been targeting is exactly this, patients with learning disability and/or autism in some of these small units that have got closed cultures." “I think we do recognise that model of care is an inherently risky model of care and so we have been inspecting many of those under this risk driven model and taking action against many of them. But there is ongoing concern about that model of care and in a few weeks’ time we will be publishing a report on our assessment of that model of care and the importance of it being changed for the benefit of the people being looked after. The model of care needs to be improved but we need to make sure we are tackling the risk.” The chief’s comments come ahead of the regulator’s state of care report, which is due to be published next week. In its report published last year the CQC highlighted a concern regarding the quality and safety of independent learning disability and autism units. In particular it warned these were at a higher risk of developing closed cultures. Read full story (paywalled) Source: HSJ, 7 October 2020)
  6. News Article
    Experts say robust legal protections are needed to inspire public confidence. The UK government has set out plans to amend drug regulations in case it decides that COVID-19 vaccines should be used before they are licensed, in a bid to roll them out more quickly. In a consultation on the proposals that ran from 28 August to 18 September the Department of Health and Social Care for England explained that if a suitable vaccine emerged with strong evidence of safety, quality, and efficacy the government would seek to license it through the usual route but could supply it in the meantime. The document added, “A COVID-19 vaccine would only be authorised in this way if the UK’s licensing authority was satisfied that there is sufficient evidence to demonstrate the safety, quality, and efficacy of the vaccine. ‘Unlicensed’ does not mean ‘untested.” The consultation, and the timeframe in which it was conducted, prompted some people to post their concerns on social media. However, the Human Medicine Regulations 2012 already allow the licensing authority to temporarily authorise the supply of an unlicensed product in response to certain public health threats, including the suspected spread of pathogens. The proposed change would allow conditions to be attached “to ensure product safety, quality, and efficacy” The 2012 regulations also give healthcare professionals and manufacturers immunity from being sued in the civil courts for the use of some unlicensed products recommended by the licensing authority in response to a public health threat. The new regulations would extend the immunity to drug companies that have not manufactured the product but placed it on the market with the approval of the licensing authority, and they clarify the consequences for a breach of conditions imposed by the authority. Social media posts play into existing concerns that many people might not accept the vaccine, as surveys indicate. Lawyers have told the Department for Health and Social Care that to inspire public confidence it must provide redress for the few people who might experience adverse effects. Bozena Michalowska, a partner specialising in product liability at the law firm Leigh Day, said, “I do not believe that people will want to play Russian roulette with their health by taking a vaccine which they know nothing about, especially when they know that the risks they take are just taken by them and not a shared risk and they will not have sufficient protection should things go wrong.” Read full story Source: The BMJ, 28 September 2020
  7. News Article
    Ten junior doctors have been removed from a struggling hospital over concerns they were being left without adequate supervision on understaffed wards. Health Education England (HEE) removed the 10 foundation year one doctors, all on a general medicine rota, from Weston General Hospital last month. The General Medical Council said the trust’s previous efforts to address the issues “have not been sufficient or sustainable”. University Hospitals Bristol and Weston Foundation Trust did not say which services HEE had removed the juniors from or what mitigations had been put in place. However, the trust told HSJ none of the positions concerned were from the hospital’s emergency department, where the GMC has already imposed conditions on juniors’ training. HEE very rarely uses its power to withdraw trusts’ trainees. HSJ reported last June the regulator had only removed two posts at trusts under enhanced monitoring since the start of 2019. William Oldfield, University Hospitals Bristol and Weston FT medical director, said in a statement to HSJ: “We recognise the seriousness of the step taken by HEE to temporarily suspend the training programme for a small number of junior doctors at Weston General Hospital. ”We are working to provide the assurance HEE require to allow this training to recommence, and in the meantime we have appropriately mitigated the impact on services at Weston.” Read full story (paywalled) Source: HSJ, 10 May 2021
  8. News Article
    Regulators have sent an improvement director into a North West acute trust amid multiple allegations of poor care and ‘cover up’ across different specialties. University Hospitals of Morecambe Bay Foundation Trust, which spent 18 months in special measures midway through the last decade, is again now the subject of significant regulatory intervention from NHS England. The regulator has appointed Simon Bennett as a board-level improvement director, which comes after he undertook a similar assignment at the struggling Stockport FT. It comes amid ongoing external investigations into the trust’s urology and trauma and orthopaedics specialties, where serious allegations have been made about attempts to cover up poor care. The trust has a troubled history of care failings and regulatory intervention, including a major maternity scandal which culminated in the Kirkup Inquiry in the first half of the 2010s, and being placed in special measures in 2014. It was widely recognised that positive progress was subsequently made to implement the inquiry recommendations and improve services, which culminated in the trust exiting special measures in late 2015, and being rated “good” by the CQC in early 2017. However, the recent allegations and investigations have again brought regulatory intervention. Read full story (paywalled) Source: HSJ, 20 April 2021
  9. News Article
    A regulator has admitted “concerns” over the software Babylon Healthcare uses in one of its digital health solutions and is exploring how to address this. The Medicines and Healthcare products Regulatory Authority’s (MHRA) concerns relate to Babylon’s symptom checker “chatbot” tool. This is used by thousands of patients, including those registered with digital primary care practice GP at Hand. Two senior figures within the agency set out the MHRA’s concerns about the tool in a letter, seen by HSJ, which was sent to consultant oncologist David Watkins following a meeting between the parties last October. Dr Watkins has raised doubts over the tool’s safety for several years, including repeatedly documenting alleged flaws in the chatbot through videos posted online. However, last year, Babylon said only 20 of Dr Watkins’ 2,400 tests resulted in “genuine errors” being identified in the software. In the letter, dated 4 December, the MHRA’s clinical director for devices Duncan McPherson and head of software related device technologies Johan Ordish said Dr Watkins’ “concerns are all valid and ones that we share”. In the letter to Dr Watkins, the two MHRA directors also said the regulator is further exploring some of the issues highlighted and the work could “be important as we develop a new regulatory framework for medical devices in the UK”. Read full story (paywalled) Source: HSJ, 4 March 2021
  10. News Article
    The development of coronavirus vaccines tweaked to target new variants will be fast-tracked in the UK and four other countries, Britain’s regulator has said, adding that “robust evidence” on effectiveness and safety will still be required for authorisation. The approach, similar to the regulatory process for the modified flu vaccine, will not need a brand new approval or “lengthy” clinical studies, the Medicines and Healthcare Products Regulatory Agency (MHRA) said on Thursday. This will "significantly reduce" the length of time it takes for the vaccines to be ready, with concern mounting over the threat posed by the South African and Brazilian variants and their ability to partially evade the body’s immune response. Under the new guidance, developers will need to provide clear evidence their adapted vaccines produce a strong immune response to the variant and meet the high safety standards outlined by the MHRA. “This is based on scientific principles and does not cut any corners on safety or effectiveness,” said Dr Christian Schneider, chief scientific officer at the MHRA. Read full story Source: The Independent, 4 March 2021
  11. News Article
    Health secretary Matt Hancock has said integrated care systems (ICS) will be rated by the Care Quality Commission (CQC). The government’s recent white paper for a new NHS bill did not discuss any change in the CQC’s legal framework to allow it to rate ICSs, which sparked uncertainty around how ICSs would be regulated. However, speaking in the House of Commons today of the “crucial” role the regulator plays in rating hospitals, Mr Hancock said: “I think that it is vital that the CQC has a similar role when it comes to ICSs.” The CQC has not confirmed what, if any, legal changes it is seeking. Currently, if the regulator wants to inspect how well a system is working, it must ask permission from the secretary of state to do so. It has carried out around 25 inspections of systems since 2017, but has not issued ratings. Giving evidence at a Parliamentary committee meeting earlier today, Sir Robert Francis, Healthwatch England chair, said: “A rating [from the CQC] that summarises the performance of the organisation to the public is a form of accountability. It doesn’t affect patient choice in quite the same way as a provider rating does, but it may be a way of explaining to the public how their system is doing.” He added that if inspectors are “continually being directed to go to the places the secretary of state chooses” then they may not carry the authority or credibility of an independent process. Read full story (paywalled) Source: HSJ, 2 March 2021
  12. News Article
    Plans to give the health secretary control over a patient safety watchdog risks “massive untold consequences” for the NHS, experts have warned. Under proposals, Matt Hancock would be able to determine which incidents the Healthcare Safety Investigation Branch (HSIB) should investigate, while also being able to remove protections for NHS staff that mean they can give evidence without fear of reprisals. The move, outlined as part of wider reforms to the NHS, would give the health secretary far greater control over the HSIB than ministers currently have over the Air Accident Investigation Branch – on which the watchdog was modelled. Experts said the proposals cut across the original intention of an independent body that would act without fear or favour and earn the confidence of NHS staff. It is designed to operate under a so-called “safe space” for NHS staff to provide evidence of what went wrong during an incident without their testimony being used against them. Martin Bromiley, chair of the Clinical Human Factors Group and member of the expert panel that recommended the creation of HSIB in 2016, said he was seriously concerned over the plans. He said: “I am concerned about the reference to lifting safe space. As it stands with the Air Accident Investigation Branch people can apply to the High Court for it to be lifted and that makes sense because a judge can consider the whole case and the longer-term impact." Carl Macrae, Professor of Organisational Behaviour and Psychology at Nottingham University Business School, told The Independent: “I am very pleased to see there are concrete plans to establish HSIB as an independent body, but I am concerned this independence appears to be undermined by giving the secretary of state the power to tell it what to investigate." “People need to be able to trust that the healthcare investigator is acting with the sole purpose of improving safety and isn’t subject to political interference.” Read full story Source: The Independent, 24 February 2021
  13. News Article
    Staff at one of England’s largest hospital trusts have been threatened with disciplinary and regulatory action if they attempt to get their second COVID-19 vaccine dose early, HSJ has learned In an all staff email today, University Hospitals Birmingham Foundation Trust said: “Any staff trying to obtain a second dose ahead of their booked sessions could be considered deliberately attempting to deceive the NHS in order to obtain medicines and, as such will be a professional conduct issue which may result in disciplinary action and/or regulatory action being taken against you. The new note indicates the FT may have had a particular problem with staff seeking and/or getting second doses. The email said that if they attended vaccination centres, staff would be refused a second dose, and be asked to leave. Staff were also asked not to try and book another appointment at a different vaccination centre or “re-enter” the system through over means. The email added: “The current supply of vaccines is allocated to us to ensure all priority groups can receive their first dose and provide protection to as many as possible.” In December the trust’s executives were heavily criticised by unions for getting their first vaccine doses, after patients didn’t show up for appointments. The trust, which has been dealing with very large numbers of covid patients especially in intensive care, has also been the subject of concerns over culture and management in recent months. Read full story (paywalled) Source: HSJ, 20 February 2021
  14. News Article
    Staff at a Midlands hospital trust told regulators they had repeatedly raised safety concerns internally without action being taken. The Care Quality Commission (CQC) has downgraded maternity services at Worcestershire Acute Hospital from “good” to “requires improvement” following an inspection prompted by the whistleblowers’ concerns. Staff had reported “continuously escalating” staffing level concerns to senior managers, but said they got “no response”. Some said they were fearful of raising concerns internally. Whistleblowers also reported delays to induction of labour, with examples of women waiting up to a week to be induced instead of one to two days. Managers said women who suffered delays were risk assessed. The CQC also identified a risk women might not be informed of significant harm caused to them or their babies following an incident, due to the way the trust was grading some babies who were admitted to the neonatal unit. However, it added: “When things went wrong, staff apologised and gave patients honest information and suitable support.” The report added the trust’s leaders were aware of the challenges in maternity, but “timely” action was not always taken to address the concerns. Read full story (paywalled) Source: HSJ, 19 February 2021
  15. News Article
    The Care Quality Commission (CQC) could regularly change its ratings of health and care providers without inspectors visiting them, under new plans from the watchdog. The CQC has said it wants to “move away from using comprehensive, on-site inspection as the main way of updating ratings” and instead use other sources like data and feedback from the public, to update ratings more regularly. At present — under the tough ratings regime introduced in 2014 in the wake of the Mid Staffs inquiry findings — it cannot change a provider’s score without carrying out a full inspection. It said in a recently published consultation that inspections “will remain an important part of how we assess quality,” but this will mostly be through more “targeted” inspections linked to significant risks to people’s safety, and the rights of vulnerable people. During the covid pandemic, CQC has targeted its on-site inspections at services where potential risks are identified, or where improvements are needed. Professor Ted Baker, the CQC’s chief inspector of hospitals, told HSJ the regulator wanted to move away from its current “fairly rigid” timetable of inspections in favour of a more “flexible” approach. Read full story (paywalled) Source: HSJ, 2 February 2021
  16. News Article
    GP practices will be included in the remit of a new patient safety watchdog, due to come in from 2023 under the new Health and Care Bill, the Department of Health and Social Care (DHSC) has said. DHSC said that it expects the new Health Services Safety Investigations Body (HSSIB) to be ‘fully operational’ in England from April 2023 – ‘subject to parliamentary clearances’. It confirmed that the statutory independent body will investigate NHS care in GP practices, although it said that the HSSIB’s ‘focus is likely to be predominantly on investigating patient safety incidents in NHS trusts’. The body will also investigate care provided by the independent healthcare sector. RCGP vice-chair Dr Gary Howsam said: ‘It is important that we have further details about how this regulator will interact with general practice, and the expectations it will have of GPs and our teams, including ensuring GPs are not implicated for systemic issues out of their control.’ Read the full article here
  17. News Article
    ‘Very heavy-handed, laborious and expensive’ inspections ‘have not been the right way’ of regulating hospitals, according to the Care Quality Commission’s (CQC) former chair. Speaking at a Royal Society of Medicine event on Wednesday, Lord David Prior, who is now the chair of NHS England, said “very few” physicians will have improved their work after reading a report from the regulator. He added that there is a role for the CQC to move in when “things are going wrong” although he is “sceptical” the regulator can actually drive improvement in hospitals. Lord Prior said: “I am highly sceptical as to whether or not CQC or any regulator can really drive improvement and drive the top hospitals to make them better. “And certainly I think there’ll be very few physicians who will say that their clinical work has improved as a result of reading a CQC report. “I think the sadness I have about CQC is that we have not been able, or it has not been able, to develop a series of predictive metrics that could replace these very heavy handed, very laborious and very expensive visits that we used to do.” Read full story (paywalled) Source: HSJ, 9 September 2021
  18. News Article
    Serious patient safety issues are being buried in confidential hospital reports, BBC Panorama has found. Freedom of Information requests revealed 111 reports, written by medical royal colleges, which NHS trusts have a duty to share. Eighty reports were given to the BBC but only 26 had been shared in full with regulators, and 16 published. The Department of Health would not comment on whether it might change the law to ensure publication. Since the 2015 Morecambe Bay maternity scandal in which 11 babies and a mother died, NHS Trusts are supposed to publish summaries of external reviews, and share them with the regulator. An earlier review into the hospital had previously identified concerns but had not been made public. Dr Bill Kirkup, who led a 2015 investigation into the Morecambe Bay scandal, said Panorama's findings were a "great disappointment". "People should know that there is something that is important enough to be looked at and they should know what the results of that scrutiny are. I can't understand what the rationale would be for withholding the existence of a report or the findings of the report. These are important matters of accountability in the public service." Read full story Source: BBC News, 19 May 2021
  19. Event
    until
    This Westminster conference will examine key issues for medicine regulation, looking at next steps for clinical trials and patient involvement. Overall, key areas for discussion include: regulation - the MHRA’s Delivery Plan for 2021-23 - the evolving role and scope of the regulator - developing new approaches to regulation - partnerships. clinical trials - priorities for change following consultation - public involvement - efficiency - transparency - issues for ensuring patients are listened to and responded to as part of the process. innovation - regulatory support - developing frameworks to facilitate safe access to innovative products & new therapies - options for streamlining & fast-track approvals. wider priorities - evidence collection - improving health outcomes - engagement with the wider life sciences ecosystem - the UK’s international role. Keynote sessions with Dr Glenn Wells, Chief Partnerships Officer, MHRA; Juliet Tizzard, Director of Policy and Partnerships, Health Research Authority; Dr Ali Hansford, Head of Regulatory Strategy Policy, ABPI; and Meindert Boysen, Director, Centre of Health Technology Evaluation, NICE. The conference will be an opportunity for stakeholders to consider the issues alongside key policy officials who are due to attend from the DHSC; DIT; MHRA; GLD; OLS; and The Scottish Government. Register
  20. Event
    This Westminster Health conference will discuss the next steps for professional healthcare regulation in the UK. It is being structured as an opportunity to consider: issues emerging from the Government’s consultations on regulating healthcare professionals measures in the Health and Social Care Act aimed at simplifying and modernising the legal framework for the regulation of health and care professions the impact of the pandemic on the landscape for professional healthcare regulation. Overall, areas for discussion include: priorities - changes in the approach to regulation ◦ placing patient safety at the heart of any new regulatory model. reform - stakeholder perspectives on proposals ◦ development of overarching criteria for regulation ◦ improving regulatory efficiency. impact - supporting regulated professionals to deliver high quality care ◦ preparing the workforce for the challenges of the future ◦ the role of regulatory reforms. safety - aligning reform with patient safety policy ◦ developing the role of regulation in promoting safe practices. education & training - next steps for providers ◦ quality assurance ◦ improving professionalism, leadership & delivery of new healthcare models. streamlining regulators - options & impact ◦ ensuring that there is capacity for any proposed changes to be effectively delivered. fitness to practise - assessing the future ◦ implications and priorities for health & wellbeing. the pandemic - how it has affected the landscape for healthcare regulation ◦ how to safeguard positive regulatory developments in upcoming reforms. Keynote contributions from Charlie Massey, Chief Executive and Registrar, General Medical Council; and Alan Clamp, Chief Executive, Professional Standards Authority. Patient Safety Learning's Helen Hughes will be one of the speakers. Register
  21. Event
    until
    The Medicines and Healthcare products Regulatory Agency (MHRA) will be holding a joint virtual Innovative Licencing and Access Pathway (ILAP) information and update session. This event will provide an opportunity for patient groups and patient experts to receive an update on the work of the ILAP, how the MHRA involve patient and public representatives, and future developments about how the MHRA are accelerating the time to market and facilitating patient access to innovative medicines. This event is open to all patient and public representatives who are involved in the work of any of the ILAP partners. Along with presentations from some of the ILAP team, a patient representative will share their experiences as a member of the pilot ILAP Patient and Public Reference Group. There will also be a panel discussion session with plenty of opportunity for questions from participants. Register
  22. Event
    This Westminster Forum conference will be an important opportunity to examine the next steps for improving patient safety in the NHS in the context of the ongoing pandemic, the updated Patient Safety Strategy, and the MHRA consultation launched to improve patient safety and regulation around medical devices. Delegates will also discuss priorities in the context of the Health and Care Bill, which includes measures aiming to strengthen the role of the Healthcare Safety Investigation Branch (HSIB) in improving patient safety. Key areas for discussion include: system learning - assessing approaches, sharing best practice, supporting the workforce, education and training, and building a learning culture patient involvement - examining priorities for involving patients and the public within patient safety regulation - options for a more flexible and adaptable approach clinical negligence - how best to improve the negligence system the role of the HSIB - including its scope going forward and informing whole system learning COVID-19 - looking at what has been learned for patient safety and how best to drive improvements in recovery from the pandemic and into the future. Register
  23. Event
    until
    While the pandemic didn’t cause all the shifts happening in healthcare, it had a major hand in accelerating and shaping the changes that will alter the healthcare landscape far into the future. Join Fierce Healthcare as we examine the tectonic transformation across healthcare. We’ll explore changing consumer expectations in access to care, the moves by major tech players and providers to reach their customers and strategies for actually paying for everything. Register
  24. Event
    Here is how to obtain a quick overview of the new Acceptable Means of Compliance (AMC) and Guidance Material (GM) addressing software published in October 2019 (Reference: ED Decision 2019/022/R). Note: Participation to Basics of regulation on the 02/03/2021 is recommended if you don't know what are AMC, GM and structure of 2017/373. Register
  25. Event
    until
    This Westminster Health Forum policy conference will examine next steps for maternity services in England. Areas for discussion include: the Ockenden Review and the NHS Long Term Plan - progress and outstanding issues in meeting recommendations and ambitions relating to maternity care care during COVID-19 - adjustments in delivery, lessons learned, and possible directions for post-pandemic maternal care and recovery of services health inequalities - looking at priorities for how they can be address and improving support key issues for innovation, safety and regulation. Agenda Register
×
×
  • Create New...